The 9th annual OPT Congress (Oligonucleotide & mRNA Therapeutics)
We are attending the 9th annual OPT Congress (Oligonucleotide & mRNA Therapeutics)
March 13-14, 2024, Boston, MA
OPT Congress is the premier conference for scientists and clinicians involved in discovering and developing oligonucleotides as therapeutics. NEW for 2024, OPT Congress is expanding its content to include programs dedicated to mRNA therapeutics. Now in its 9th year, this unique event brings together leading chemists, biologists, toxicologists, CMC experts, regulatory specialists, and technology providers to discuss advances in next-generation oligonucleotides and mRNA therapeutics.
Stop by the Areterna booth to discover how we are fueling the next generation of raw materials and services to enable mRNA and oligo therapeutics.
Speaking Session
Join us for an exciting presentation by May Guo, Chief Commercial Officer of Areterna, who will discuss our cap analogs and modified NTPs.
Presentation Title:
Democratizing mRNA Therapeutics with Novel Cap Analogs & Modified NTPs
- Showcasing novel cap analogs and their discovery
- Unravelling novel modified NTPs
- Leveraging mRNA capping assays and paired capped/uncapped mRNA standards
Date: Conference Day 1. Wednesday, March 13, 2024
Time: 10:15AM EST
Speaker: May Guo, Chief Commercial Officer, Areterna LLC
Raw Materials and Services to Enable mRNA and Oligo Therapeutics
Whether your focus is on manufacturing mRNA or pioneering groundbreaking mRNA therapeutics, we are here to support you.
Our products are designed to elevate your research to new heights.